Keiichi Hanaki Selected Research

Keiichi Hanaki Research Topics

2	Insulin Resistance 01/2021 - 03/2019
2	Type 2 Diabetes Mellitus (MODY) 03/2019 - 03/2019
2	Fetal Growth Retardation (Intrauterine Growth Retardation) 12/2017 - 08/2005
2	Pediatric Obesity 06/2014 - 04/2007
2	Gynecomastia 06/2011 - 11/2007
2	Antley-Bixler Syndrome Phenotype 05/2009 - 08/2004
1	Familial Hypophosphatemic Rickets (X-Linked Hypophosphatemia) 01/2024
1	Rickets (Rachitis) 01/2024
1	Pain (Aches) 01/2024
1	Anorexia Nervosa 01/2019
1	Thinness 01/2019
1	Hyperinsulinism (Hyperinsulinemia) 12/2017
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2017
1	Pseudohypoaldosteronism 01/2017
1	Birth Weight (Birth Weights) 12/2015
1	Scoliosis 03/2015
1	Disease Progression 01/2015
1	Airway Obstruction (Choking) 01/2013
1	Acanthosis Nigricans 01/2013
1	Hypertrophy 01/2013
1	Donohue Syndrome 01/2013
1	Hirsutism 01/2013
1	Weight Gain 01/2013
1	Castleman Disease (Castleman's Disease) 10/2012
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 02/2012
1	46,XY Disorder of Sex Development (Male Pseudohermaphroditism) 05/2009
1	Disorders of Sex Development (Intersexuality) 05/2009
1	XX Disorders of Sex Development 46 (Female Pseudohermaphroditism) 05/2009
1	Virilism (Virilization) 05/2009
1	Familial Hypoadrenocorticism 03/2009
1	Adrenal Insufficiency (Adrenal Gland Hypofunction) 03/2009
1	Addison Disease (Addison's Disease) 03/2009
1	Obesity 04/2007
1	Pituitary Dwarfism 08/2003
1	Leukemia 08/2003
1	Aplastic Anemia (Anemia, Hypoplastic) 08/2003

2	Insulin (Novolin)FDA Link 01/2021 - 01/2013
2	Insulin ReceptorIBA 01/2021 - 01/2013
2	AldosteroneIBA 01/2017 - 01/2015
2	due to increased aromatase activity familial gynecomastiaIBA 06/2011 - 11/2007
2	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 05/2009 - 08/2004
2	Oxidoreductases (Dehydrogenase)IBA 05/2009 - 08/2004
1	Monoclonal AntibodiesIBA 01/2024
1	calcium phosphateIBA 01/2024
1	Fibroblast Growth Factor-23IBA 01/2024
1	Phosphorus (Red Phosphorus)IBA 01/2024
1	burosumabIBA 01/2024
1	Fibronectins (Fibronectin)IBA 01/2021
1	Glucagon-Like Peptide 1 (GLP 1)IBA 03/2019
1	fucoidanIBA 03/2019
1	Glucose (Dextrose)FDA LinkGeneric 03/2019
1	Hemoglobins (Hemoglobin)IBA 03/2019
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 03/2019
1	ZincIBA 01/2019
1	Ascorbic Acid (Vitamin C)FDA LinkGeneric 01/2019
1	CarbohydratesIBA 01/2019
1	Messenger RNA (mRNA)IBA 12/2017
1	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 01/2017
1	Nonsense Codon (Nonsense Mutation)IBA 12/2015
1	ReninIBA 01/2015
1	Insulin-Like PeptidesIBA 01/2013
1	Oxygen (Dioxygen)IBA 01/2013
1	Interleukin-6 (Interleukin 6)IBA 10/2012
1	HLA-DRB1 Chains (HLA DRB1)IBA 02/2012
1	Aromatase deficiencyIBA 05/2009
1	Hydrocortisone (Cortisol)FDA LinkGeneric 03/2009
1	SaltsIBA 03/2009
1	Adrenocorticotropic Hormone (ACTH)FDA Link 03/2009
1	Orphan Nuclear ReceptorsIBA 03/2009
1	Estrogens (Estrogen)FDA Link 11/2007
1	Type 4 Melanocortin Receptor (Melanocortin-4 Receptor)IBA 04/2007
1	Somatomedin Receptors (Somatomedin Receptor)IBA 08/2005
1	Growth Hormone (Somatotropin)IBA 08/2003

3	Therapeutics 01/2024 - 08/2003
1	Diet Therapy (Therapy, Diet) 03/2019
1	Activities of Daily Living (ADL) 03/2015
1	Continuous Positive Airway Pressure 01/2013